We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Summit Therapeutics Plc | SUMM | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 20.50 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 20.50 |
| Top Posts |
|---|
Posted at 22/1/2021 17:10 by chrisatrdg My reply from Summit this afternoonIt would appear all is ok but I have today Sold 3,900 shares at a small loss & now retain 1,400 shares.My Sales were on the basis that I could not risk loosing a substantial part of my investment. I would add that after all these years (many) I have made a loss of £144 but now I will just sit back & watch. Reply below: Chris, I hope you are well, and thank you for your note. The filings with the SEC in January are mainly to finalize the process regarding the shares that were issued in November based on our capital raising efforts at that time. I’ve included the link to our press release that was issued to announce the closing of this funding here: hxxps://www.summittx The filings in January register the shares that were issued to those who participated in the fundraising, and also covers some shares as a part of previous fundraisings in late 2019 and 2020 to complete the process. This is not a new fundraising effort beyond what we’ve previously disclosed. Please let me know if you have any further questions, as I am happy to help. Best, Dave Dave Gancarz Vice President, Investor Relations & Corporate Strategy A picture containing object, lamp, drawing, light Description automatically generated |
Posted at 14/12/2020 21:07 by chrisatrdg Currently I am for the first time at just above break even since the crash & glad I topped up recently by selling some UK biotech shares & some InfraStrata shares.Good luck to all fellow investors lets hope 2021 will be better than 2020 it just has to be.Regards to all. |
Posted at 07/11/2020 14:11 by chrisatrdg Summit Announces Closing of Private Placement of $50 MillionEdit: Note new investors - this company is still to play for. |
Posted at 18/9/2020 21:44 by chrisatrdg Hi All - I am with Interactive Investors & waiting to be able to exchange my shares into the new company for some £121. Has anyone been contacted by their investment provider yet ?Edit: Until I phoned today II had not been notified by their 'provider' this is now being put in place I await their secure message. |
Posted at 20/8/2020 12:20 by chrisatrdg All resolutions passed: |
Posted at 19/8/2020 11:41 by chrisatrdg Anyone following todays meeting's outcome.'On 19 August 2019, Summit will hold a Court Meeting at 1:30pm BST followed by a General Meeting at 1:40pm BST to approve the introduction of a new US-incorporated holding company to be effected by means of a Scheme of Arrangement under Part 26 of the Companies Act 2006. Below, you will find the Scheme Circular and supporting documents.' PS: I have heard that to transfer our ADDS will cost us 5 cents an ADD. |
Posted at 03/7/2020 14:04 by chrisatrdg The following was a reply I had today having sent Richard an e-mail this morning with questions about the AGM.For me it is the end of an era & somewhat sad.Not sure where this leaves us UK investors? ----Original Message----- From: Richard Pye To: XXXXXX Sent: Fri, 3 Jul 2020 11:25 Subject: Automatic reply: Summit AGM I have now left Summit. For investor related enquiries, please contact Michelle Avery (michelle.avery@summ Best wishes, Richard |
Posted at 07/5/2020 17:13 by chrisatrdg Positive report yesterday seems now being reflected in Summits resurge on the NASDAQ today:Summit Therapeutics PLC (SMMT) Gains As Market Dips: What You Should Know May 06, 2020, 05:45:16 PM EDT By Zacks.com 'In the latest trading session, Summit Therapeutics PLC (SMMT) closed at $3.11, marking a +0.33% move from the previous day. This change outpaced the S&P 500's 0.7% loss on the day. At the same time, the Dow lost 0.92%, and the tech-heavy Nasdaq gained 0.51%. Investors will be hoping for strength from SMMT as it approaches its nex t earnings release. On that day, SMMT is projected to report earnings of -$0.08 per share, which would represent year-over-year growth of 60%. Our most recent consensus estimate is calling for quarterly revenue of $2.84 million, up 787.5% from the year-ago period. Any recent changes to analyst estimates for SMMT should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook. Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 26.26% higher. SMMT is currently a Zacks Rank #1 (Strong Buy). The Medical - Drugs industry is part of the Medical sector. This group has a Zacks Industry Rank of 13, putting it in the top 6% of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow SMMT in the coming trading sessions, be sure to utilize Zacks.com.' |
Posted at 27/1/2020 22:12 by chrisatrdg Hi All - Holding in Barclays may not be a good idea as I am sure they told me that because Summit was being delisted from AIM they would have to sell any shares I had with them prior to delisting.I am in the process of putting my Summit share certificates through my Interactive Investors account through Crest & posted the first of my share certificates today receipt Tuesday.I am still waiting for my balance of shares previously held with Barclays but I understand talking to Summits share registra the certificates are on their way to me (please note I instructed Barclays back on the 13th December). Interactive Investors will then put my shares back onto AIM & then through Crest the shares then to be transferred onto the NASDAQ through The Bank of New York Mellon CUSIP: 86627R102 who hold the ADD's on behalf of Summit Therapeutics.The basis of the exchange is 1 (One) ADD's for every 5 shares held currently on AIM. I am following advice given by Interactive Investors (II). I will shortly find out if it all works as I will be asking II to exchange the share certificates I sent them today. |
Posted at 23/1/2020 12:44 by chrisatrdg I agree with you kirk6 & I am moving onto the NASDAQ soon & I am now with Interactive Investors & have just rounded my investment to 51,000 shares by Buying a mere 755 shares as the current share price is cheaper than chips & by being with Interactive Investors once my share certs get added in I can move onto the NASDAQ as Interactive Investors also trade on the NASDAQ.I may add a few more before the close in February. Now showing as Strong BuyEdit: NASDAQ now on the rise up 5.72% at $1.65. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
